North America Clinical Nutrition Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The North America Clinical Nutrition Market is segmented by Route of Administration, Application (Malnutrition, Metabolic Disorders, Gastrointestinal Diseases, Neurological Diseases, Cancer, Other Indications), End-User, and Geography.

Market Snapshot

Study Period: 2018 - 2026
Base Year: 2021
CAGR: 5.5 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The Clinical Nutrition Market in North America is well-established, owing to multiple factors contributing to its overall growth. Some of the primary factors include a large geriatric population base, the growing burden of chronic diseases, and increased awareness in the society regarding clinical nutrition.

Recent years have observed high focus by the companies and hospitals, toward health and wellness, aging, and disease prevention. For a number of chronic diseases, such as coronary artery disease, ischemic stroke, diabetes, and few cancer indications, preventive medical nutrition is effective and steadily being adopted by hospitals and clinics in North America.

Moreover, healthcare expenditure continues to grow faster than economic growth in most countries. The presence of equitable, responsive, and efficient health systems across the North American countries has also contributed to the maximum share of GDP, for healthcare expenditure. Such factors drive the demand for clinical nutrition in North America.

Scope of the Report

The report on North America clinical nutrition market is segmented by route of administration, application, end user, and geography.

Clinical nutrition products help to keep the patient healthy and aid to improve the metabolic system of the body by providing adequate supplements, such as minerals, vitamins, and others. Additionally, the high birth rate and a higher number of premature births also demand advanced clinical nutrition.

Report scope can be customized per your requirements. Click here.

Key Market Trends

Application in Malnutrition is Estimated to Witness Healthy Growth Over the Forecast Period

Medical nutrition therapy (MNT) is important in preventing diabetes, managing existing diabetes, and preventing, or at least slowing, the rate of development of diabetes complications. It is, therefore, important at all levels of diabetes prevention. MNT is also an integral component of diabetes self-management education. MNT plays a role in all three levels of diabetes-related prevention targeted by the U.S. Department of Health and Human Services.

Moreover, the demand for these therapies has increased due to increasing prevalence of diabetes in North American countries. For instance, as per a report by the International Diabetes Federation 2019 report, there were 48 million diabetes cases in North America and Caribbean in 2019, which is expected to increase to 56 million by 2030. This is expected to increase the demand for medical nutrition therapy for diabetes as well, which will boost the market growth.


Competitive Landscape

There are several international major players, as well as domestic companies in the United States, Canada, and Mexico, which creates a good competitive scenario for companies in the North American clinical nutrition market. Some of the major companies having a good presence across the North American region include Abbott, Nestle, Baxter B Braun, and Danone Nutricia.

Table of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Prevalence of Metabolic Disorders

      2. 4.2.2 Increasing Spending on Healthcare by Government and Private Foundations

      3. 4.2.3 Growing Aging Population in North American Countries

    3. 4.3 Market Restraints

      1. 4.3.1 Imprecise Perception about Clinical Nutrition

      2. 4.3.2 Reduction in Birth Rates

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Route of Administration

      1. 5.1.1 Oral and Enteral

      2. 5.1.2 Parenteral

    2. 5.2 By Application

      1. 5.2.1 Nutritional Support in Malnutrition

      2. 5.2.2 Nutritional Support in Metabolic Disorders

      3. 5.2.3 Nutritional Support in Gastrointestinal Diseases

      4. 5.2.4 Nutritional Support in Neurological Diseases

      5. 5.2.5 Nutritional Support in Cancer

      6. 5.2.6 Nutritional Support in Other Indications

    3. 5.3 By End User

      1. 5.3.1 Pediatric

      2. 5.3.2 Adult

    4. 5.4 Geography

      1. 5.4.1 North America

        1. United States

        2. Canada

        3. Mexico


    1. 6.1 Company Profiles

      1. 6.1.1 Abbott Laboratories (Abbott Nutrition)

      2. 6.1.2 B. Braun Melsungen AG

      3. 6.1.3 BASF SE

      4. 6.1.4 Baxter

      5. 6.1.5 Nestle SA

      6. 6.1.6 Danone Nutricia

      7. 6.1.7 Fresenius Kabi

      8. 6.1.8 Perrigo Company PLC

    2. *List Not Exhaustive

**Subject to Availability
**Competitive Landscape Covers - Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The North America Clinical Nutrition Market market is studied from 2018 - 2026.

The North America Clinical Nutrition Market is growing at a CAGR of 5.5% over the next 5 years.

Abbott Laboratories (Abbott Nutrition), Nestlé SA, Baxter, B. Braun Melsungen AG, Danone Nutricia are the major companies operating in North America Clinical Nutrition Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!